Skip to main content

Table 1 The relationship between MAZ and clinicopathological characteristics in 243 patients with prostate cancer

From: MAZ promotes prostate cancer bone metastasis through transcriptionally activating the KRas-dependent RalGEFs pathway

Parameters

Number of cases

MAZ expression

P values

Low

High

Age (years)

  ≤ 72

121

68

53

0.124

  > 72

122

56

66

 

Differentiation

 Well/moderate

96

51

45

0.293

 Poor

147

67

80

 

Serum PSA

  < 84.7

121

72

49

 

  > 84.7

122

34

88

< 0.001*

Gleason grade

  ≤ 7

102

79

23

 

  > 7

141

35

106

< 0.001*

Operation

 TURP

71

41

30

 

 Needle biopsy

204

113

91

 

 PP

83

39

44

 

 TURP+BO

35

16

19

 

 BO

21

9

12

0.419

BM-status

 nBM

158

104

54

 

 BM

85

18

67

< 0.001*

  1. Abbreviation: PSA, Prostate-specific antigen; TURP, Trans Urethral Resection Prostate;PP, Prior Prostatectomy; BO, Bilateral Orchiectomies; SD, Standard deviation; IHC, Immunological Histological Chemistry; BM, Bone Metastasis